 SAN DIEGO, CA ACCESSWIRE September 21, 2022 Ensysce Biosciences, Inc. Ensysce or the Company NASDAQ:ENSCOTC PINK:ENSCW, a clinical-stage biotech company applying transformative chemistry to improve prescription drug safety to reduce abuse and overdose, today announced that management will present during Benzingas All Access investor event taking place Friday, September 23, 2022. Dr. Lynn Kirkpatrick, Chief Executive Officer of Ensysce, is scheduled to host a presentation and QA session during the event as follows. 